World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30054
World Ranking
14029
National Ranking
7116

Michael W. Konstan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael W. Konstan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 295 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael W. Konstan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael W. Konstan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael W. Konstan is affiliated with Case Western Reserve University in the United States and has an extensive record of contributions primarily in the field of Medicine, with a significant focus on Pulmonary and Respiratory Medicine. Their research spans several subfields including Epidemiology, General Health Professions, Public Health, Environmental and Occupational Health, and Cardiology and Cardiovascular Medicine.

The scientist's work concentrates on specific topics such as Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and airway disorders, Opioid Use Disorder Treatment, Inhalation and Respiratory Drug Delivery, Health Policy Implementation Science, and Substance Abuse Treatment and Outcomes.

Selected recent publications illustrate the focus areas and include the following papers:

  • The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices, 2020, Drug and Alcohol Dependence
  • Increasing life expectancy in cystic fibrosis: Advances and challenges, 2021, Pediatric Pulmonology
  • Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF), 2020, Journal of Cystic Fibrosis
  • Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design, 2021, Annals of the American Thoracic Society
  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation, 2020, UNC Libraries

Frequent collaborators in their research include:

  • Donald R. VanDevanter
  • Edith T. Zemanick
  • Nicole Mayer-Hamblett
  • Shari Bolen
  • Sharon Walsh

Publication venues where Michael W. Konstan frequently publishes their work are:

  • Journal of Cystic Fibrosis
  • UNC Libraries
  • Pediatric Pulmonology
  • The Journal of Pediatrics
  • JAMA Network Open

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

    Jennifer L Taylor-Cousar;Anne Munck;Edward F McKone;Cornelis K van der Ent

  • Effect of high-dose ibuprofen in patients with cystic fibrosis.

    Michael W. Konstan;Pamela J. Byard;Charles L. Hoppel;Pamela B. Davis

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

    Frank J. Accurso;Steven M. Rowe;J. P. Clancy;Michael P. Boyle

  • Inflammatory cytokines in cystic fibrosis lungs.

    T L Bonfield;J R Panuska;M W Konstan;K A Hilliard

  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

    J. P. Clancy;Steven M. Rowe;Frank J. Accurso;Moira L. Aitken

  • Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

    Michael W. Konstan;Kathleen A. Hilliard;Tonya M. Norvell;Melvin Berger

  • Genetic Modifiers of Lung Disease in Cystic Fibrosis

    Mitchell L. Drumm;Michael W. Konstan;Mark D. Schluchter;Allison Handler

  • Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

    André M. Cantin;Dominik Hartl;Michael W. Konstan;James F. Chmiel

  • Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

    Michael W. Konstan;Wayne J. Morgan;Steven M. Butler;David J. Pasta

  • Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

    T L Bonfield;M W Konstan;P Burfeind;J R Panuska

  • Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis

    Michael W. Konstan;Steven M. Butler;Mary Ellen B. Wohl;Marcia Stoddard

  • Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.

    Michael W. Konstan;Patrick A. Flume;Matthias Kappler;Raphaël Chiron

  • Current understanding of the inflammatory process in cystic fibrosis: onset and etiology.

    Michael W. Konstan;Melvin Berger

  • Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.

    Michael W. Konstan;Pamela B. Davis;Jeffrey S. Wagener;Kathleen A. Hilliard

  • A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

    Michael P Boyle;Scott C Bell;Michael W Konstan;Susanna A McColley

  • Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

    Ronald L. Gibson;Julia Emerson;Sharon McNamara;Jane L. Burns

  • Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

    Elliott C. Dasenbrook;William Checkley;Christian A. Merlo;Michael W. Konstan

  • A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

    Joanne M. Quan;Harm A.W.M. Tiddens;Judy P. Sy;Sheila G. McKenzie

  • Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

    M. W. Konstan;K. A. Milliard;T. M. Norvell;M. Berger

Frequent Co-Authors

Wayne J. Morgan
Wayne J. Morgan University of Arizona
Bonnie W. Ramsey
Bonnie W. Ramsey University of Washington
John P. Clancy
John P. Clancy Cystic Fibrosis Foundation
Steven M. Rowe
Steven M. Rowe University of Alabama at Birmingham
Melvin Berger
Melvin Berger CSL (Switzerland)
Pamela B. Davis
Pamela B. Davis Case Western Reserve University
Richard B. Moss
Richard B. Moss Stanford University
Margaret Rosenfeld
Margaret Rosenfeld University of Washington
J. Stuart Elborn
J. Stuart Elborn Queen's University Belfast
Claire E. Wainwright
Claire E. Wainwright University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in pursuing a medical career but want more flexible or alternative options, there are several online degrees and career pathways available in the healthcare field. For those looking to become advanced practice nurses without holding a prior nursing degree, direct entry online msn programs offer an accelerated route to a master’s in nursing, welcoming applicants from diverse backgrounds.

Individuals concerned about admissions requirements may consider easy nursing programs to get into or schools that waive traditional entrance exams such as the TEAS or HESI. If standardized tests are a barrier, explore a nursing school without teas test for a smoother application process.

For those interested in the administrative side of healthcare, medical billing and coding online schools that accept financial aid can provide career-ready training with financial assistance options. These online programs open doors to in-demand jobs, offering flexibility for working professionals or career changers.

Best Scientists Citing Michael W. Konstan

Trending Scientists

Recently Published Articles